Safety of Remdesivir Treatment in COVID-19 Patients Requiring Hemodialysis

NCT04854837 · clinicaltrials.gov ↗

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Covid19
End Stage Renal Failure on Dialysis

Interventions

DRUG: Remdesivir

Sponsor

Semmelweis University